Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC long-teRm Evaluation
Interim analysis of the REASSURE (Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC long-teRm Evaluation) study: patient characteristics and safety according to prior use of chemotherapy in routine clinical practice.
Interim analysis of the REASSURE ( Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC long-teRm Evaluation ) study : patient characteristics and safety according to prior use of chemotherapy in routine clinical practice .